BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Deals

  3SBio Acquires CDMO Business From Canada’s Therapure For $290 Million

  September 5, 2017

   · 

  1 min read
• Deals

  3SBio Pays $290 Million For Therapure’s CDMO Biz

  September 5, 2017

   · 

  4 min read
• Policy

  Ortho Dermatologics Submits New Drug Application To The FDA For Psoriasis Treatment IDP-118

  September 5, 2017

   · 

  4 min read
• Drug Development

  Eiger Biopharma Announces FDA Orphan Drug Designation Granted For Pegylated Interferon Lambda In Hepatitis Delta Virus Infection

  September 5, 2017

   · 

  4 min read
• FDA Grants Orphan Drug Status To Cellect’s ApoGraft For Acute GvHD And Chronic GvHD

  September 5, 2017

   · 

  5 min read
• Pharm Country

  Alexion To Present At Upcoming Investor Conferences

  September 5, 2017

   · 

  1 min read
• Business

  Morphotek Announces An Agreement With Fujirebio Diagnostics, Inc. To Commercialize The CA125 II Assay As A Companion Diagnostic For Farletuzumab

  September 5, 2017

   · 

  5 min read
• BioMidwest

  Amnio Technology Announces National Launch Of PalinGen InovoFlo To Supplement Tissue For Protection, Cushioning And Lubrication

  September 5, 2017

   · 

  2 min read
• Pharm Country

  Synergy Pharma Secures $300 Million Debt Financing

  September 5, 2017

   · 

  6 min read
• Drug Development

  Deciphera Announces FDA Orphan Drug Designation For DCC-2618 For The Treatment Of Glioblastoma Multiforme And Anaplastic Astrocytoma

  September 5, 2017

   · 

  3 min read